Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 9 studies | 18% ± 3% | |
mesothelial cell | 5 studies | 20% ± 3% | |
type II pneumocyte | 5 studies | 19% ± 4% | |
epithelial cell | 4 studies | 34% ± 19% | |
GABAergic neuron | 4 studies | 22% ± 5% | |
astrocyte | 4 studies | 21% ± 5% | |
glutamatergic neuron | 4 studies | 42% ± 15% | |
adipocyte | 3 studies | 20% ± 2% | |
oligodendrocyte | 3 studies | 22% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1366.70 | 1444 / 1445 | 100% | 20.34 | 183 / 183 |
stomach | 100% | 1063.18 | 359 / 359 | 100% | 14.41 | 285 / 286 |
intestine | 100% | 1283.38 | 966 / 966 | 99% | 13.83 | 524 / 527 |
lung | 99% | 1181.75 | 574 / 578 | 100% | 18.14 | 1155 / 1155 |
breast | 100% | 1021.60 | 458 / 459 | 99% | 12.13 | 1102 / 1118 |
thymus | 100% | 1159.80 | 653 / 653 | 98% | 12.80 | 595 / 605 |
pancreas | 100% | 1092.61 | 328 / 328 | 97% | 12.28 | 173 / 178 |
bladder | 100% | 793.62 | 21 / 21 | 96% | 12.83 | 486 / 504 |
uterus | 97% | 607.95 | 165 / 170 | 98% | 14.36 | 450 / 459 |
kidney | 100% | 681.16 | 89 / 89 | 94% | 13.98 | 851 / 901 |
prostate | 99% | 659.87 | 243 / 245 | 95% | 8.24 | 478 / 502 |
liver | 100% | 879.42 | 226 / 226 | 93% | 8.87 | 378 / 406 |
brain | 93% | 511.71 | 2445 / 2642 | 99% | 10.97 | 700 / 705 |
skin | 98% | 675.96 | 1766 / 1809 | 94% | 10.75 | 444 / 472 |
ovary | 89% | 447.39 | 161 / 180 | 99% | 10.35 | 427 / 430 |
adrenal gland | 100% | 620.83 | 258 / 258 | 76% | 4.64 | 175 / 230 |
adipose | 100% | 1528.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 892.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.99 | 1 / 1 |
blood vessel | 100% | 1264.82 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 423.30 | 769 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 11.06 | 27 / 29 |
heart | 93% | 468.22 | 797 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 83% | 478.75 | 771 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 2.38 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045859 | Biological process | regulation of protein kinase activity |
GO_0007399 | Biological process | nervous system development |
GO_0007283 | Biological process | spermatogenesis |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0001932 | Biological process | regulation of protein phosphorylation |
GO_0030154 | Biological process | cell differentiation |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_0061575 | Molecular function | cyclin-dependent protein serine/threonine kinase activator activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CCNYL1 |
Protein name | Cyclin Y like 1 Cyclin-Y-like protein 1 |
Synonyms | |
Description | FUNCTION: Key regulator of Wnt signaling implicated in various biological processes including male fertility, embryonic neurogenesis and cortex development. Activates the cyclin-dependent kinase CDK16, and promotes sperm maturation. . |
Accessions | ENST00000420822.1 ENST00000420321.1 C9IYB8 Q8N7R7 H7C0P7 ENST00000392209.7 [Q8N7R7-3] ENST00000295414.8 [Q8N7R7-1] H7BZD2 ENST00000650811.1 A0A494C0K2 ENST00000339882.9 [Q8N7R7-2] ENST00000452312.1 |